| Parameter | Score |
|---|---|
| 1. Scale | A |
| 2. Study Population | A |
| 3. Samples | C |
| 4. Measurand | A |
| 5. Pre-Analytical | A |
| 6. Replicate Analysis | A |
| 7. Steady State | C |
| 8. Outlier Analysis | C |
| 9. Normality | B |
| 10. Variance Homogeneity | C |
| 11. ANOVA | B |
| 12. CI | A |
| 13. No of Results | C |
| 14. Concentrations | A |
| 15. Total Score | C3,7,8,10,13 |
| Comment |
| Parameter | Score |
|---|---|
| Matrix | Serum |
| Measurand | Procollagen carboxy-terminal propeptide (PICP) |
| Unit | ug / L |
| Overall Analytical Principle Method | Immunoassay; RIA |
| Number of Subjects | 10 |
| Number of Subjects included in BV estimation | 10 |
| Ethinicity | Unknown |
| Age Mean / Median | |
| Age Min | 27.0 |
| Age Max | 52.0 |
| Age SD | |
| Number of Males | 6 |
| Number of Females | 4 |
| State of Well Being |
Healthy (excl pregnant)
|
| Diseases | |
| Study Duration Length | 3 |
| Study Duration Units | Month |
| Sampling Intervals, e.g. X sample(s) per Interval Unit | 3 |
| Interval Units | Month |
| Sampling Times | Start Time:
8:30
End Time: 9:00 |
| Number of Samples | 10 |
| Average Number of Samples Used for BV Estimation | 10.0 |
| Average Number of Replicates | 3.0 |
| Estimates of CVi | 8.6 |
| Calculated Confidence Intervals of CVi | Lower: 7.47, Upper: 10.11 |
| Estimates of CVg | 17.6 |
| Calculated Confidence Intervals of CVg | Lower: 12.13, Upper: 31.14 |
| Analytical CV | 2.7 |
| Calculated Confidence Intervals of Analytical CV | Lower: 2.46, Upper: 2.99 |
| Measurand Mean | |
| Measurand Min | |
| Measurand Max | |
| Measurand SD |